As cell therapies quickly advance from pre-clinical stage into clinical and commercial applications, the design and implementation of scalable manufacturing platform technologies continues to be a focus for the field. Despite the successful commercialization of several cell therapies, bottlenecks in manufacturing throughput and capacity continue to hinder patient access to these life-saving treatments.

This webinar explores the current landscape and limitations of cell therapy manufacturing platforms and shares insights into how to choose a technology platform that assures flexibility in process development and scalability for clinical and commercial success.

You will learn about:

  • Challenges and opportunities associated with current cell therapy manufacturing platforms
  • The flexibility of translating CAR T manufacturing processes to the Lonza Cocoon® Platform
  • How to ensure process flexibility that enables rapid implementation of iterative manufacturing improvements

Speaker: Peter Yates, Ph.D, Product Management Director, Personalized Medicine

By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content
Latest briefing from the Knowledge Center